Previous Section | Index | Home Page |
13 Nov 2008 : Column 1375Wcontinued
Mr. Heald: To ask the Secretary of State for Health what the cost to his Department of provision of office facilities to (a) special advisers and (b) press officers (i) was in the last 12 months and (ii) has been since 1997-98. [233527]
Mr. Bradshaw: It is not possible to calculate the cost of the provision of office facilities to special advisers and press officers for the period in question.
Miss McIntosh: To ask the Secretary of State for Health (1) how many prescription items have been dispensed by dispensing doctors in (a) Vale of York constituency and (b) England in the last three years; [232991]
(2) how many prescription items have been dispensed in the community by community pharmacists, appliance contractors and dispensing doctors in (a) Vale of York constituency and (b) England in the last three years. [233210]
Dawn Primarolo: The number of prescription items that have been dispensed in the community by community pharmacists, appliance contractors and by dispensing doctors is available for primary care trusts (PCTs) in England. The figures are based on a one in 20 sample of prescriptions. It is not possible to separate the figures for community pharmacists and appliance contractors so the combined figure is given in each case. The figures provided are for the PCT which is the closest match to the Vale of York, namely North Yorkshire and York PCT.
Number of prescription items dispensed in the community in England by dispenser type in calendar years from 2005 to 2007( 1) | ||||
Thousand | ||||
Region | Dispenser type | 2005 | 2006 | 2007 |
(1) Personally administered items are excluded from this analysis. Source: PCA data. |
Anne Milton: To ask the Secretary of State for Health what the average life expectancy was of a patient diagnosed with HIV in each year from 2001. [234983]
Dawn Primarolo: A recently published article in The Lancet (2008; 372:293-99) provides estimates of life expectancy for HIV-infected adults receiving combination antiretroviral therapy. It is based on analysis of over 43,000 patients from industrialised countries, including some from the UK. The median life expectancy for such patients was 63 years for those diagnosed at age 20 and 67 years for those diagnosed at age 35.
Figures are not available for each year since 2001, but the estimated life expectancy increased between the first period studied in the research (1996-99) and the last (2003-05). For those patients starting combination therapy at age 20, life expectancy increased from an estimated 56.1 years in 1996-99 to 69.4 years in 2003-05. Equivalent figures at age 35 are from 60 years to 72.3 years.
Anne Milton: To ask the Secretary of State for Health what the rates of infection for (a) HIV, (b) genital herpes, (c) syphilis, (d) gonorrhea and (e) chlamydia were in each month from 2001 to 2008. [235086]
Dawn Primarolo: Rates of diagnoses for individuals accessing care in genito-urinary medicine (GUM) clinics reported to the Health Protection Agency (HPA) are not available by month but are available by year.
The following table gives the rate of diagnoses of anogenital herpes, primary and secondary infectious syphilis, gonorrhoea, Chlamydia and new HIV diagnoses and HIV infected individuals accessing care, for all ages in the United Kingdom, per 100,000 population; 2001 to 2007, the latest year available.
As HIV is a long-term, chronic condition, many individuals are living with HIV infection who were diagnosed in previous years. Therefore, the last column in the table shows the rates of diagnosed HIV infection among the general population (all ages). The rate will be higher among those aged 15 to 59 years. There are also persons living with HIV infection in the UK who are unaware of their infectionthis proportion was approximately one in every three HIV-infected persons in 2007.
In addition to cases in GUM clinics, the National Chlamydia Screening Programme (NCSP) provides screening to asymptomatic people aged under 25 years in England and was launched in April 2003. The following table shows the positivity among those aged 13 to 24 years screened for Chlamydia during the period 1 April 2003 to 30 June 2008. The figures presented are positivity measures among those screened and not rates of infection in the general population.
Table 2: Positivity among those aged 13 to 24 years screened for Chlamydia , National Chlamydia Screening Programme: 1 April 2003 to 30 June 2008. | ||||
Quarter | Number of negative screens (a) | Number of positive screens (b) | Total number of screens( 1) | Positivity (a/a+b) 100( 1) |
(1) Total screens includes screens with insufficient sample, inhibitory and equivocal test results and therefore might not equal number of negative + number of positive screens Source: The NCSP Core Dataset. |
Next Section | Index | Home Page |